Saudi Food and Drug Administration (SFDA) has approved Swedish Orphan Biovitrum AB (Sobi)’s Orfadin (nitisinone)
Saudi Food and Drug Administration (SFDA) has approved Swedish Orphan Biovitrum AB (Sobi)’s Orfadin (nitisinone) capsules in all strengths (2 mg, 5... Read More
Sanofi to expand its generic portfolio in Middle East with acquisition of significant stake in Globalpharma
Sanofi has acquired a majority stake in Globalpharma from Dubai Investments as the French drug maker targets the booming regional pharmaceuticals sector.... Read More